Samsung Seoul Hospital Becomes First in Korea to Perform Dual-Energy Ablation
Utilizing Both Radiofrequency and Pulsed Field Energies with a Single Catheter
Tailored Arrhythmia Treatment Strategies According to Cardiac Wall Thickness
On Younggeun: "Personalized Therapies Now Possible for Each Patient"
Samsung Seoul Hospital announced on October 7 that it has become the first in Korea to perform dual-energy ablation (DEA), a procedure for atrial fibrillation treatment that utilizes both radiofrequency (RF) and pulsed field (PF) energies together.
Professor On Younggeun of Samsung Medical Center is performing Dual-Energy Ablation (DEA). Samsung Medical Center
View original imageDEA is an arrhythmia treatment that allows both pulsed field ablation and radiofrequency ablation to be performed using a single catheter. Its key feature is that the most appropriate energy can be selected according to the patient's condition and the area being treated.
For instance, when treating the heart wall close to the esophagus or phrenic nerve, pulsed field ablation is used as it poses relatively less risk of damaging surrounding tissues. If energy needs to be delivered to thick or deep cardiac tissue, radiofrequency ablation is employed instead.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
On Younggeun, Director of the Arrhythmia Center and Professor of Cardiology at Samsung Seoul Hospital, stated, "By combining traditional RFA and next-generation PFA, we can now establish more flexible and individualized treatment strategies for patients. We will continue to drive innovation in arrhythmia therapies and strive to deliver an even better treatment experience for our patients."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.